175 related articles for article (PubMed ID: 12164795)
1. Membranes for therapeutic apheresis.
Nakaji S; Yamamoto T
Ther Apher; 2002 Aug; 6(4):267-70. PubMed ID: 12164795
[TBL] [Abstract][Full Text] [Related]
2. Clinical hemocompatibility of double-filtration lipoprotein apheresis comparing polyethersulfone and ethylene-vinyl alcohol copolymer membranes.
Krieter DH; Jeyaseelan J; Rüth M; Lemke HD; Wanner C; Drechsler C
Artif Organs; 2021 Sep; 45(9):1104-1113. PubMed ID: 33617653
[TBL] [Abstract][Full Text] [Related]
3. Present status of apheresis technologies: Part 1. Membrane plasma separator.
Sueoka A
Ther Apher; 1997 Feb; 1(1):42-8. PubMed ID: 10225780
[TBL] [Abstract][Full Text] [Related]
4. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations.
Sueoka A
Ther Apher; 2000 Jun; 4(3):211-2. PubMed ID: 10910022
[TBL] [Abstract][Full Text] [Related]
6. Effect of membrane trapping in plasma fractionator on separative characteristics.
Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
8. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
9. The selective therapeutic apheresis procedures.
Sanchez AP; Cunard R; Ward DM
J Clin Apher; 2013 Feb; 28(1):20-9. PubMed ID: 23420592
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen salvage during DF Thermo using Evaflux-5A plasma fractionators.
Nakashima M; Yasui M; Ihara A
Ther Apher Dial; 2012 Oct; 16(5):472-7. PubMed ID: 23046373
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two filter combinations for low-density lipoprotein apheresis by membrane differential filtration: a prospective crossover controlled clinical study.
Matic G; Kohlschein P; Wallstab U; Tiess M; Winkler R; Prophet H; Ramlow W; Schuff-Werner P
Artif Organs; 2002 Apr; 26(4):371-7. PubMed ID: 11952509
[TBL] [Abstract][Full Text] [Related]
12. [Apheresis Techniques].
Mariano M
G Ital Nefrol; 2017 Sep; 34(5):73-88. PubMed ID: 28963829
[TBL] [Abstract][Full Text] [Related]
13. The fluctuation of skin perfusion pressure in hemodialysis patients treated with LDL apheresis therapy: A comparison of LDL adsorption and double filtration plasmapheresis.
Yoshimura H; Yoshikawa Y; Noguchi Y; Totani T; Kusuta R; Shimazu K; Tanaka A; Komura K
J Clin Apher; 2023 Aug; 38(4):362-367. PubMed ID: 36367055
[TBL] [Abstract][Full Text] [Related]
14. Applications of membrane technologies for therapeutic apheresis.
Sueoka A
Ther Apher; 1998 Nov; 2(4):252-6. PubMed ID: 10227750
[TBL] [Abstract][Full Text] [Related]
15. The current status of therapeutic apheresis devices in the United States.
Siami GA; Siami FS
Int J Artif Organs; 2002 Jun; 25(6):499-502. PubMed ID: 12117288
[TBL] [Abstract][Full Text] [Related]
16. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
17. An effective LDL removal filter for the treatment of hyperlipidemia.
Matsuda Y; Sueoka A; Nosé Y
Artif Organs; 1995 Feb; 19(2):129-34. PubMed ID: 7763191
[TBL] [Abstract][Full Text] [Related]
18. Present status of apheresis technologies: Part 2. Membrane plasma fractionator.
Sueoka A
Ther Apher; 1997 May; 1(2):135-46. PubMed ID: 10225759
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients.
Suzuki M; Yamane S; Matsugane T; Nobuto T; Azuma N; Nishide T; Shinomiya M; Saito K; Sasaki N; Nosé Y
Artif Organs; 1996 Apr; 20(4):296-302. PubMed ID: 8860710
[TBL] [Abstract][Full Text] [Related]
20. Optimum albumin concentration of supplementation fluid for double filtration plasmapheresis.
Mineshima M; Agishi T; Hasuo Y; Era K; Suzuki T; Teraoka S; Ota K
Artif Organs; 1992 Oct; 16(5):510-3. PubMed ID: 10078302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
